Time-action profile of insulin lispro and regular insulin in patients with type 1 diabetes and diabetic nephropathy

被引：0
|
作者：
Rave, R
Sawicki, PT
Heise, T
Heinemann, L
机构：
[1] Profil Inst Metab Res, Neuss, Germany
[2] Univ Dusseldorf, Klin Stoffwechselkrankheiten & Ernahrung, Dusseldorf, Germany
来源：
DIABETOLOGIA | 2000年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
755
引用
收藏
页码：A197 / A197
页数：1
相关论文
共 50 条
  • [1] Time-action profile of an inhaled insulin preparation in comparison to insulin Lispro and regular insulin
    Bott, S
    Heinemann, L
    Rave, K
    Sha, S
    Willavize, SA
    Carroll, RS
    Gruber, S
    Lee, JD
    Heise, T
    DIABETOLOGIA, 2000, 43 : A46 - A46
  • [2] Time-action profile of an inhaled insulin preparation in comparison to insulin lispro and regular insulin
    Heise, T
    Rave, K
    Bott, S
    Sha, S
    Willavize, SA
    Carroll, RS
    Gruber, S
    Lee, JD
    Heinemann, L
    DIABETES, 2000, 49 : A10 - A10
  • [3] Time-action profile for intravenously infused insulin aspart and insulin lispro in type 1 diabetic subjects
    Hamilton-Wessler, M
    Buchanan, T
    Hathout, E
    Kolaczynski, J
    Bajwa, R
    Nakao, S
    Ross, E
    Bergman, RN
    DIABETES, 2002, 51 : A99 - A99
  • [4] Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin
    Rave, K
    Bott, S
    Heinemann, L
    Sha, S
    Becker, RHA
    Willavize, SA
    Heise, T
    DIABETES CARE, 2005, 28 (05) : 1077 - 1082
  • [5] Time-Action Profile of Technosphere Insulin in Children with Type 1 Diabetes
    Haller, Michael J.
    Jones, Marisa C.
    Bhavsar, Sunil
    Kaiserman, Kevin B.
    DIABETES THERAPY, 2023, 14 (03) : 611 - 617
  • [6] Time-action profile of insulin glulisine (GLU) versus regular human insulin (RHI) and insulin lispro (IL) in obese subjects
    Frick, AD
    Burger, F
    Scholtz, H
    Becker, RHA
    DIABETES, 2004, 53 : A124 - A124
  • [7] Comparison of insulin lispro and regular human insulin in the treatment of patients with diabetic nephropathy.
    Mattoo, V
    Malone, JK
    Bajaj, R
    Tiku, A
    Wangnoo, SK
    Seshiah, V
    Sridhar, GR
    Dharmalingam, M
    Rao, VP
    Vishwanathan, V
    Kumar, H
    Rangwala, S
    DIABETOLOGIA, 2002, 45 : A364 - A365
  • [8] Intravenous administration of insulin lispro versus regular insulin in patients with type 1 diabetes
    Stiller, R
    Kothny, T
    Gudat, UHK
    Anderson, JH
    Seger, M
    Johnson, RD
    Richardson, MS
    Haslbeck, M
    DIABETES, 1999, 48 : A115 - A115
  • [9] Time-action profile of inhaled insulin
    Heise, T
    Traut, T
    Heinemann, L
    DIABETES, 1996, 45 : 819 - 819
  • [10] Time-action profiles of premixed formulations of insulin lispro and NPL-insulin.
    Heise, T
    Weyer, C
    Serwas, A
    Heinrichs, S
    Osinga, J
    Roach, P
    Woodworth, J
    Heinemann, L
    DIABETES, 1997, 46 : 586 - 586
12345